Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-COV-2 Mpro conformational changes induced by covalently bound ligands
Gláucio Monteiro Ferreira, Thales Kronenberger, Arun Kumar Tonduru, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 22, pp. 12347-12357
Open Access | Times Cited: 24

Showing 24 citing articles:

COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
Thales Kronenberger, Stefan Laufer, Thanigaimalai Pillaiyar
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103579-103579
Open Access | Times Cited: 44
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination
Thanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9376-9395
Closed Access | Times Cited: 59
Key dimer interface residues impact the catalytic activity of 3CLpro, the main protease of SARS-CoV-2
Juliana C. Ferreira, Samar Fadl, Wael M. Rabeh
Journal of Biological Chemistry (2022) Vol. 298, Iss. 6, pp. 102023-102023
Open Access | Times Cited: 44
Structure-Based Identification of Naphthoquinones and Derivatives as Novel Inhibitors of Main Protease Mpro and Papain-like Protease PLpro of SARS-CoV-2
Lucianna Helene Santos, Thales Kronenberger, Renata G. Almeida, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 24, pp. 6553-6573
Open Access | Times Cited: 34
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches
Qiang Shao, Muya Xiong, Jiameng Li, et al.
Chemical Science (2023) Vol. 14, Iss. 18, pp. 4681-4696
Open Access | Times Cited: 13
Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics
Chris Chun-Yiu Chan, Qian Guo, Jasper Fuk‐Woo Chan, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 9, pp. 4028-4044
Open Access | Times Cited: 4
Design, Synthesis, and Unprecedented Interactions of Covalent Dipeptide-Based Inhibitors of SARS-CoV-2 Main Protease and Its Variants Displaying Potent Antiviral Activity
Philipp Flury, Nadine Krüger, Katharina Sylvester, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Ouratein D, a Biflavanone From Ouratea spectabilis, Alleviates Betacoronavirus Infection by Mitigating Inflammation, Lung Damage and Viral Replication
A. Monteiro, Kátia Michelle Freitas, Ana Clara M. Montuori‐Andrade, et al.
Phytotherapy Research (2025)
Closed Access
Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors
Runchana Rungruangmaitree, Sakao Phoochaijaroen, Aunlika Chimprasit, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
The SARS-CoV-2 Mpro Dimer-Based Screening System: A Synthetic Biology Tool for Identifying Compounds with Dimerization Inhibitory Potential
Ernawati Arifin Giri-Rachman, Vergio V. Effendy, Muhammad Hamzah Syaifullah Azmi, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 2, pp. 509-520
Open Access | Times Cited: 3
Structure-Based Discovery of Thiosemicarbazones As SARS-CoV-2 Main Protease Inhibitors
Vinícius Gonçalves Maltarollo, Elany Barbosa da Silva, Thales Kronenberger, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 959-985
Closed Access | Times Cited: 7
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
Mateus Sá Magalhães Serafim, Simone Queiroz Pantaleão, Elany Barbosa da Silva, et al.
Frontiers in Drug Discovery (2023) Vol. 3
Open Access | Times Cited: 6
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking
Vázquez Mendoza Luis Heriberto, Humberto L. Mendoza‐Figueroa, J. Benjamín García‐Vázquez, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3987-3987
Open Access | Times Cited: 10
Inhibitor induced conformational changes in SARS-COV-2 papain-like protease
Gláucio Monteiro Ferreira, Thanigaimalai Pillaiyar, Mário Hiroyuki Hirata, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 10
A Structural Comparison of SARS-CoV-2 Main Protease and Animal Coronaviral Main Protease Reveals Species-Specific Ligand Binding and Dimerization Mechanism
Chien‐Yi Ho, Jiaxin Yu, Yu‐Chuan Wang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5669-5669
Open Access | Times Cited: 8
Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro
Débora Bublitz Anton, Jeferson Camargo de Lima, Bruno Rampanelli Dahmer, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3007-3035
Closed Access | Times Cited: 1
Sunflower Trypsin Monocyclic Inhibitor Selected for the Main Protease of SARS-CoV-2 by Phage Display
Graziele Cristina Ferreira, Verônica de Moraes Manzato, Débora Noma Okamoto, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 11, pp. 1813-1822
Open Access | Times Cited: 1
Structure-based identification of naphthoquinones and derivatives as novel inhibitors of main protease Mpro and papain-like protease PLpro of SARS-CoV-2
Lucianna Helene Santos, Thales Kronenberger, Renata G. Almeida, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
In-silico investigation of 4-nitro-N-1H-pyrazol-3-ylbenzamide towards its potential use against SARS-CoV-2: a DFT, molecular docking and molecular dynamics study
S.V. Niranjana, B.S. Chethan, Mahesha Mahesha, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 21, pp. 11435-11455
Closed Access | Times Cited: 1
ENGENHARIA QUÍMICA E A INDÚSTRIA FARMACÊUTICA: UMA LONGA HISTÓRIA DE AVANÇO TECNOLÓGICO
Carlos Daniel Silva Luna, Marco Aurelio Andrade, Maria Luiza Taufic Valerio, et al.
Revista Contemporânea (2024) Vol. 4, Iss. 6, pp. e4644-e4644
Open Access
The Conformational Space of the SARS-CoV-2 Main Protease Active Site Loops Is Determined by Ligand Binding and Interprotomer Allostery
Ethan Lee, Sarah Rauscher
Biochemistry (2024) Vol. 64, Iss. 1, pp. 32-46
Open Access
Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
Future Pharmacology (2024) Vol. 4, Iss. 4, pp. 825-852
Open Access
In silico study identifies peptide inhibitors that negate the effect of non-synonymous mutations in major drug targets of SARS-CoV-2 variants
Roshny Prasad, Harikrishnan Ajith, Naveen Kumar Chandrakumaran, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 19, pp. 9551-9561
Open Access | Times Cited: 1
Inhibition potential of the major secondary metabolites isolated from anacardium occidentale against Mpro enzyme from COVID-19 virus using molecular docking and dynamics studies
Antônio MG Pereira, Lucas Lima Bezerra, Márcia Machado Marinho, et al.
Journal of Analytical & Pharmaceutical Research (2022) Vol. 11, Iss. 2, pp. 32-37
Open Access | Times Cited: 1
Page 1

Scroll to top